How RWE supports biomarker-driven NSCLC strategy across Europe
How a European real‑world evidence cohort informed biomarker testing and treatment in NSCLC
Resources and expert insights
Check out the latest thinking from our team — explore our blog, read white papers, watch videos, and more.
Viewing results for:
Filter by type
Filter by topic
Search
Read more
Real‑world evidence to support regulatory and HTA submissions
How market access teams use RWD to support regulatory, HTA, and payer submissions with outcomes and cost evidence
Understanding oncology patient populations and treatment pathways using real‑world data
How discovery‑stage teams use real‑world data to make confident decisions
Removing uncertainty in real-world evidence and under-represented populations
Under-represented populations introduce uncertainty in real-world evidence. Population coverage determines whether results apply across regions;
BC Mosaic, our AI-powered trusted research environment for life sciences and healthcare
Explore these FAQs to learn how BC Mosaic, our AI-powered TRE, enables secure, compliant research on clinical, real-world, and multi-omics data.
Your ultimate BC Catalyst FAQs: driving smarter decisions in life sciences
Explore the full BC Catalyst FAQs and learn how our AI‑native analytics platform improves decision‑making.
Choosing a secure workspace for data analysis and collaboration
A buyer’s guide to evaluating secure workspaces for regulated healthcare and life sciences research projects.
EHDS Q&A: Understanding the basics – Part 1
Part 1 of our EHDS Q&A explains why compliance is urgent, outlining key deadlines, enforcement rules, and the financial risks of falling behind.
EHDS Q&A: Understanding the basics – Part 2
Part 2 of our EHDS Q&A focuses on readiness and implementation, detailing the infrastructure, governance, and changes needed to be ready on time.